More on VSTM
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.23 |
|
|||
| Open | $9.23 | ||||
| 52 Wk High | $2.43 | ||||
| 52 Wk Low | $1.05 | ||||
| Day High | $9.37 | ||||
| Day Low | $8.53 | ||||
| P/E | N/A | ||||
| EPS | $-1.79 | ||||
| Volume | 6,092,241 | ||||
- H.C. Wainwright Reiterates Buy Rating on Verastem (VSTM)
- Verastem (VSTM) PT Raised to $14 at Mizuho, 'Reaffirming Potential Best-in-Class Potential'
- Verastem (VSTM) PT Raised to $19 at RBC Capital
- Form 8-K Verastem, Inc. For: Oct 14
- Form 424B5 Verastem, Inc.
- Form 424B5 Verastem, Inc.
- Form 8-K Verastem, Inc. For: Oct 12
- Verastem reports early VS-7375 trial data across multiple cancer types
- Verastem Oncology prices $250M stock and warrant offering
- Verastem Oncology Announces Pricing of $250 Million Offering of Common Stock and Pre-Funded Warrants
Entities mentioned with VSTM
- FDA | View Related Stories »
- 13G | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Show More...
